Trypanosoma cruzi: Acute and long-term infection in the vertebrate host can modify the response to benznidazole

Experimental Parasitology

Volumn 118, Issue 3, 2008, Pages 315-323

  Caldas, Sérgio ^a   Santos, Fabiane M ^a   Lana, Marta de ^a   Diniz, Lívia F ^a   Machado Coelho, George L L ^a   Veloso, Vanja M ^a   Bahia, Maria T ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

benznidazole; Bz; Chagas disease; Chemotherapy; Cure control; Drug resistance; Nf; nifurtimox; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOG; DRUG SENSITIVITY; EXPERIMENTAL INFECTION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PARASITE ISOLATION; PARASITE VIRULENCE; PARASITEMIA; PRIORITY JOURNAL; TREATMENT RESPONSE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; CHAGAS DISEASE; CYCLOPHOSPHAMIDE; DOGS; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; NITROIMIDAZOLES; PARASITEMIA; SERIAL PASSAGE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

CANIS FAMILIARIS; MUS; TRYPANOSOMA CRUZI; VERTEBRATA;

EID: 38649127571     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2007.08.016     Document Type: Article

References (38)

1. Andrade S.G., Andrade V., Brodskyn C., Magalhães J.B., and Netto M.B. Immunological response of Swiss mice to infection with three different strains of Trypanosoma cruzi. Annals of Tropical Medicine and Parasitology 79 (1985) 397-407
2. Andrade S.G., Rassi A., Magalhães J.B., Ferriolli F.F., and Luquetti A.O. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Transactions of the Royal Society of Tropical Medicine and Hygiene 86 (1992) 624-626
3. Araújo, I.B., 2000. Estudo Morfobiológico e Isoenzimático de Amostras de Trypanosoma cruzi, Trypanosoma rangeli Isoladas de Casos Humanos, de Vetores e de Mamíferos Silvestres da Região do Médio e Alto Rio Negro-Amazonas, MSc Thesis, Instituto Oswaldo Cruz, Rio de Janeiro.
4. Aufderheide A.C., Salo W., Madden M., Streitz J., Buikstra J., Guhl F., Arriaza B., Renier C., Wittmers Jr. L.E., Fornaciari G., and Allison M. A 9,000-year record of Chagas' disease. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 2034-2039
5. Ávila H., Gonçalves A.M., Nehme N.S., Morel C.M., and Simpson L. Schizodeme analysis of Trypanosoma cruzi stocks from South and Central America by analysis of PCR-amplified minicircle variable region sequences. Molecular and Biochemical Parasitology 42 (1990) 175-187
6. Braga M.S., Lauria-Pires L., Argañaraz E.R., Nascimento R.J., and Teixeira A.R. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Revista do Instituto de Medicina Tropical de São Paulo 42 (2000) 157-161
7. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4 (1962) 389-396
8. Brener Z., Chiari E., and Alvarenga N.J. Observations on Trypanosoma cruzi strains maintained over an 8-year period in experimentally inoculated mice. Revista do Instituto de Medicina Tropical de São Paulo 16 (1974) 39-46
9. Buckner F.S., Wilson A.J., White T.C., and Van Voorhis W.C. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy 42 (1998) 3245-3250
10. Camargo E.P. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic Trypanosomes in liquid media. Revista do Instituto de Medicina Tropical de São Paulo 12 (1964) 93-100
11. Cançado J.R. Long term evaluation of etiological treatment of chagas disease with benznidazole. Revista do Instituto de Medicina Tropical de São Paulo 44 (2002) 29-37
12. Carneiro M., Romanha A.J., and Chiari E. Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Memórias do Instituto Oswaldo Cruz 86 (1991) 387-393
13. Chagas C. Nova tripanosomíase humana: estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., agente etiológico de nova entidade mórbida do homem. Memórias do Instituto Oswaldo Cruz 1 (1909) 159-218
14. de Ferreira H.O. Tratamento da forma indeterminada da doença de Chagas com Nifurtimox e Benzonidazol. Revista da Sociedade Brasileira de Medicina Tropical 23 (1990) 209-211
15. Dvorak J.A., and Howe C.L. The effects of Lampit (Bayer 2502) on the interaction of Trypanosoma cruzi with vertebrate cells in vitro. The American Journal of Tropical Medicine and Hygiene 26 (1977) 58-63
16. Filardi L.S., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 81 (1987) 755-759
17. Gomes M.L., Macedo A.M., Vago A.R., Pena S.D., Galvão L.M., and Chiari E. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Experimental Parasitology 88 (1998) 28-33
18. Guedes P.M., Fietto J.L.R., Lana M., and Bahia M.T. Advances in Chagas disease chemotherapy. Anti-Infective Agents in Medicinal Chemistry 5 (2006) 175-186
19. Guedes P.M., Veloso V.M., Tafuri W.L., Galvão L.M., Carneiro C.M., Lana M., Chiari E., Soares K.A., and Bahia M.T. The dog as model for chemotherapy of the Chagas' disease. Acta Tropica 84 (2002) 9-17
20. Lana M., and Chiari C.A. Comparative biological characterization of Berenice and Berenice-78 strains of Trypanosoma cruzi isolated from the same patient at different times. Memórias do Instituto Oswaldo Cruz 81 (1986) 247-253
21. Lauria-Pires L., Braga M.S., Vexenat A.C., Nitz N., Simões-Barbosa A., Tinoco D.L., and Teixeira A.R. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. The American Journal of Tropical Medicine and Hygiene 63 (2000) 111-118
22. Marretto J.P., and Andrade S.G. Biochemical behavior of Trypanosoma cruzi strains isolated from mice submitted to specific chemotherapy. Revista da Sociedade Brasileira de Medicina Tropical 27 (1994) 209-215
23. Miyamoto C.T., Gomes M.L., Marangon A.V., Araújo S.M., Bahia M.T., Lana M., and Toledo M.J. Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes. Experimental Parasitology 112 (2006) 198-201
24. Murta S.M., Krieger M.A., Montenegro L.R., Campos F.F., Probst C.M., Ávila A.R., Muto N.H., de Oliveira R.C., Nunes L.R., Nirdé P., Bruna-Romero O., Goldenberg S., and Romanha A.J. Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi. Molecular and Biochemical Parasitology 146 (2006) 151-162
25. Murta S.M., and Romanha A.J. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology 116 Pt 2 (1998) 165-171
26. Salgado J.A., Garcez P.N., Olliveira C.A., and Galizzi J. Revisão clínica atual do primeiro caso humano descrito de Doença de Chagas. Revista do Instituto de Medicina Tropical de São Paulo 4 5 (1962) 330-337
27. Santos F.R., Pena S.D., and Epplen J.T. Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Human Genetics 90 (1993) 655-656
28. Schlemper Jr., B.R., 1982. Caracterização de Cepas do Trypanosoma cruzi Isoladas de Pacientes com Diferentes Formas Clínicas da Doença de Chagas, PhD Thesis, Universidade Federal do Rio de Janeiro.
29. Suasnábar D.F., Arias E., Streiger M., Piacenza M., Ingaramo M., Del Barco M., and Amicone N. Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients. Revista do Instituto de Medicina Tropical de São Paulo 42 (2000) 99-110
30. Toledo M.J., Bahia M.T., Carneiro C.M., Martins-Filho O.A., Tibayrenc M., Barnabé C., Tafuri W.L., and Lana M. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents and Chemotherapy 47 (2003) 223-230
31. Toledo M.J., Gasperi M.V., Marques de Araújo S., and Lana M. Berenice 62 and Berenice 78 strains of Trypanosoma cruzi: comparison of their susceptibility to benzidazole. Memórias do Instituto Oswaldo Cruz 90 suppl. (1995) 201
32. Toledo M.J., Guilherme A.L., Silva J.C., de Gasperi M.V., Mendes A.P., Gomes M.L., and Marques de Araújo S. Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil. Revista do Instituto de Medicina Tropical de São Paulo 39 (1997) 283-290
33. Veloso V.M., Carneiro C.M., Toledo M.J., Lana M., Chiari E., Tafuri W.L., and Bahia M.T. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Memórias do Instituto Oswaldo Cruz 96 (2001) 1005-1011
34. Veloso V.M., Romanha A.J., Lana M., Murta S.M., Carneiro C.M., Alves C.F., Borges E.C., Tafuri W.L., Machado-Coelho G.L., Chiari E., and Bahia M.T. Influence of the long-term Trypanosoma cruzi infection in vertebrate host on the genetic and biological diversity of the parasite. Parasitology Research 96 (2005) 382-389
35. Villarreal D., Nirdé P., Hide M., Barnabé C., and Tibayrenc M. Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites. Antimicrobial Agents and Chemotherapy 49 (2005) 2701-2709
36. Viotti R., Vigliano C., Armenti H., and Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. American Heart Journal 127 (1994) 151-162
37. Voller A., Bidwell D.E., and Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bulletin of the World Health Organization 53 (1976) 55-65
38. WHO, 2002. WORLD HEALTH ORGANIZATION. Control of Chagas' disease. Second Report of the WHO Expert Committee. WHO Technical Report Series. 905, Geneva.